Iovance Biotherapeutics(IOVA) - 2023 Q1 - Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Sara Pellegrino – Senior Vice President, Investor Relations and Corporate Communications Fred Vogt – Interim President and Chief Executive Officer Igor Bilinsky – Chief Operating Officer Jim Ziegler – Executive Vice President, Commercial Friedrich Finckenstein – Chief Medical Officer Jean-Marc Bellemin – Chief Financial Officer Conference Call Participants Michael Yee – Jefferies Peter La ...